Hugo Mendoza takes on new role at Masters Speciality Pharma
April 9, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing t Masters Speciality Pharma
Masters Speciality Pharma has appointed Hugo Mendoza as its new business development director for the Caribbean and Central America territories. …
Former health minister tells NHS to embrace technology
April 9, 2014Medical Communications, Sales and Marketing Jeremy Hunt, autism, brain in hand, google, paperless, telehealth
The Labour MP and former health minister Ben Bradshaw has urged the National Health Service to do more when it …
Pharma needs ‘radical change’ says report
April 9, 2014Medical Communications, Sales and Marketing Chris Stirling, GSK, KPMG, digital
The pharma industry needs a complete overhaul of its entire business model with a greater focus on the patient, according …
Google Glass has ‘endless potential’ for Parkinson’s
April 9, 2014Medical Communications, Research and Development, Sales and Marketing Google glass, Parkinson's, Samsung, google
A new experiment by a British University is putting Google Glass to the test with Parkinson’s patients to see if …
EMA transparency agenda sees more delay
April 9, 2014Medical Communications, Sales and Marketing AbbVie, EFPIA, EMA, Europe, InterMune, alltrials, parliament, transparency
The European Medicines Agency is to further delay its policy over clinical trial transparency, saying it needs more time to …
Spectrum appoints Dr Dalna Harvey as regulatory project manager
April 8, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Spectrum, Wyeth, woodley
Spectrum Regulatory Solutions, a company that provides a consultancy to the healthcare industry, has added to its regulatory team by …
Dr Eliot Forster to lead MedCity
April 8, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boris Johnson, medcity
Dr Eliot Forster has been appointed chairman of MedCity Limited by the London mayor Boris Johnson. Dr Forster has 20 …
MedCity will be ‘concierge’ for life sciences
April 8, 2014Medical Communications, Research and Development, Sales and Marketing Boris Johnson, Francis Crick Institute, life sciences, medcity
MedCity, the new entity seeking to capitalise on the so-called ‘golden triangle’ of medical and life sciences R&D organisations between …
Alkermes schizophrenia drug shines in Phase III
April 8, 2014Medical Communications, Research and Development, Sales and Marketing Abilify, Alkermes, aripiprazole, schizophrenia
Alkermes’ investigational schizophrenia drug has met its primary endpoint in a pivotal trial, leading the firm to seek regulatory approval …
Virgo health bolsters senior team with new hires
April 8, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Tonic Life, Virgo
The newly named Virgo Consumer Health & Wellbeing welcomes two new joiners – Matthew Coy and Reena Patel (both pictured), …
Takeda and Lilly hit with $9 billion Actos damages bill
April 8, 2014Medical Communications, Sales and Marketing Actos, Takeda, law case, lilly
A US jury has ordered Japanese firm Takeda Pharmaceutical to pay $6 billion (£3.6 billion) in punitive damages, over claims …
Michael Griffith becomes executive vice president of inVentiv Health
April 8, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentiv
inVentiv Health has appointed Michael Griffith as its new executive vice president. In this capacity, Griffith will head inVentiv’s commercial …
Roche joins forces with PatientsLikeMe
April 8, 2014Medical Communications, Research and Development, Sales and Marketing Novartis, PatientsLikeMe, Roche, UCB, real-word data
PatientsLikeMe has set up a five-year agreement with Genentech, Roche’s biologics arm, to allow the firm access to patients’ real-world …
Pfizer breast cancer drug combo aces trial
April 7, 2014Femera, Pfizer, breast cancer, oncology, palbociclib
Under fire Ranbaxy sold to Sun Pharma for $4 billion
April 7, 2014Manufacturing and Production, Sales and Marketing FDA, Ranbaxy, Sun Pharma, deal, hamburg, manufacturing
Sun Pharmaceutical Industries has bought struggling drugmaker Ranbaxy Laboratories in a deal that will see the two companies become the …
Celgene ‘stops Mylan entering market’
April 6, 2014Sales and Marketing Celgene, Mylan, Revlimid, myeloma
Generic manufacturer Mylan is suing Celgene in a spat over allowing copycat versions of existing cancer drugs – Revlimid and …
Alzheimer’s disease: pharma’s greatest challenge
April 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, Alzheimer's, Alzheimer’s, Eisai, Lunt, Pfizer, galantamine, karran, priddy
Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …
NICE U-turn on Roche cancer drug
April 4, 2014Medical Communications, Sales and Marketing NICE, Roche, Tarceva, U-turn
Roche’s lung cancer drug Tarceva has been given a reprieve to treat relapsed lung cancer patients in the NHS after …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
